Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF
NCT01605175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2015-11-17
Summary
The aim of this study is to prospectively identify, at diagnosis of the disease, factors predictive of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF.
Conditions
Sponsors & Collaborators
-
University of Athens
collaborator OTHER -
Laikο General Hospital, Athens
collaborator OTHER -
Evangelismos Hospital
lead OTHER
Principal Investigators
-
Nikos Viazis, Director · Evangelismos Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- Greece
Study Locations
More Related Trials
-
Monitoring of Patients With Inflammatory Bowel Diseases: the Experience of the Reference Center of the Emilia-Romagna
NCT06721767 ·Status: RECRUITING
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Endomicroscopy in IBD Patients
NCT01417728 ·Status: COMPLETED
-
Immunological Characteristics of Preclinical IBD
NCT05698745 ·Status: RECRUITING
-
Long-term Outcome of TNF Alpha Therapy in IBD
NCT04575701 ·Status: COMPLETED
-
Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
NCT06516341 ·Status: RECRUITING
-
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study
NCT02364973 ·Status: COMPLETED
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases
NCT03615287 ·Status: UNKNOWN
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Development of Novel Fecal Microbial Biomarkers for Inflammatory Bowel Disease
NCT05598489 ·Status: UNKNOWN
-
Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in Inflammatory Bowel Disease (IBD)
NCT00915044 ·Status: UNKNOWN
-
Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)
NCT06777251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Construction and Validation of a Predictive Model for the Efficacy of Different Biologics in Inflammatory Bowel Disease
NCT07181525 ·Status: RECRUITING
-
Collection of Specimens for Study of Inflammatory Bowel Disease
NCT00086554 ·Status: COMPLETED
-
Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM
NCT01663142 ·Status: COMPLETED
-
Surgically Resected Crohn's Disease Patients: Prognostic Factors for Re-operation and New Score Building
NCT03150238 ·Status: UNKNOWN
-
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
NCT06015789 ·Status: COMPLETED
-
Remote Monitoring of IBD
NCT05886322 ·Status: UNKNOWN
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients
NCT06772350 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gene Expression in Inflammatory Bowel Disease
NCT01171872 ·Status: ENROLLING_BY_INVITATION
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
NCT01731665 ·Status: RECRUITING